Close Menu

NEW YORK (360Dx) – At-home health testing firm LetsGetChecked today announced it closed $30 million in a Series B financing round that it will use to continue scaling up its direct-to-consumer diagnostics brand in the US, Canada, and Europe.

The funding will also support development of the firm's core technology platform and expansion of manufacturing and logistical capabilities throughout North America, the firm added.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.